Multiple Sclerosis Trial, Recruiting (NCT06777134)

Multiple Sclerosis Trial, Recruiting NCT06777134 Sponsor: Berivan Beril Kılıç Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06777134 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your multiple sclerosis disability level must fall within a certain range (a score between 0 and 4.0 on a scale doctors use to measure MS disability — confirm with trial site)
You must have access to the internet through a fast smartphone or computer
You must score at least 21 out of 30 on a short memory and thinking ability test called the MoCA
You must be able to walk with at least some level of independence (a certain minimum level on a walking ability scale — confirm with trial site)

Who may not be able to join:

People who have significant hearing or vision problems
People who are currently taking part in any exercise program
People who have other neurological (brain/nerve), heart, or bone and joint conditions alongside their MS
People who have had an MS relapse (flare-up) or a change in their MS medication within the last 6 months
People whose physical condition prevents them from being able to participate in exercise activities
People who have other health conditions that affect how their body carries oxygen, such as severe anemia or blocked arteries in the legs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905069496158

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06777134

Sponsor: Berivan Beril Kılıç

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +905069496158

More information: https://clinicaltrials.gov/study/NCT06777134

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your multiple sclerosis disability level must fall within a certain range (a score between 0 and 4.0 on a scale doctors use to measure MS disability — confirm with trial site)
You must have access to the internet through a fast smartphone or computer
You must score at least 21 out of 30 on a short memory and thinking ability test called the MoCA
You must be able to walk with at least some level of independence (a certain minimum level on a walking ability scale — confirm with trial site)

Who may not be able to join:

People who have significant hearing or vision problems
People who are currently taking part in any exercise program
People who have other neurological (brain/nerve), heart, or bone and joint conditions alongside their MS
People who have had an MS relapse (flare-up) or a change in their MS medication within the last 6 months
People whose physical condition prevents them from being able to participate in exercise activities
People who have other health conditions that affect how their body carries oxygen, such as severe anemia or blocked arteries in the legs

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Berivan Beril Kılıç

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

10 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Pelvic floor muscle dysfunction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov